UPMC settles $38M whistleblower lawsuit for Medicare fraud

The University of Pittsburgh Medical Center (UPMC) has settled a lawsuit brought by whistleblowers who alleged surgeons at the health system were performing unnecessary procedures to bolster earnings. 

The case will now be settled out of court for $38 million. UPMC does not admit wrongdoing. 

According to coverage in the Pittsburgh Post-Gazette, the lawsuit started in 2012 with a complaint from three UPMC clinicians who sued the health system and 13 staff neurosurgeons, claiming they unfairly billed Medicare for medically unnecessary procedures and received bonus pay as a result. 

The Department of Justice (DoJ) declined to intervene in the case. Related false claim allegations were previously settled in 2016 by UPMC for $2.5 million in fines paid to the government. After which time, the three plaintiffs continued to pursue a new lawsuit on three claims not addressed in that initial settlement. 

The three plaintiffs are set to receive $11 million for moving this second case forward. The payout is a reward to whistleblowers for bringing fraud cases to the attention of the government. The remaining $27 million will be paid by UPMC as a punitive fine to the government directly.  

According to the plaintiffs, the $38 million settlement marks one of the largest false claim recovery judgements on record to not involve the DoJ. 

Read the full story from the Pittsburgh Post-Gazette at the link below.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

A string of executive orders from the White House created serious concerns among radiologists and other healthcare providers throughout the United States. The American College of Radiology issued a statement to help guide its members through the chaos. 

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025. 

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.